Robert Orlowski, Florence Maude Thomas Cancer Research Professor at The University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day: Observational multicenter Italian study to analyze the profile of myeloma patients who survived 10 years or longer finds age >60, hypoalbuminemia dx, of anti-myeloma therapies equal or >3 as significant prognostic factors.”
“Long-Term Survival with Multiple Myeloma: An Italian Experience”
Authors: Francesca Fazio, Martina Gherardini, Elena Rossi, Maurizio Martelli, Maria Teresa Petrucci et al.
More posts featuring Robert Orlowski.
